Dendrimer conjugate of [4-(tetradecanoylamino)benzyl]phosphonic acid (s32826) as an autotaxin inhibitor

ACS Medicinal Chemistry Letters

Volumn 5, Issue 1, 2014, Pages 34-39

  Fisher, Natalie ^a,b   Hilton Bolt, Timothy ^b   Edwards, Michael G ^b   Haxton, Katherine J ^b   McKenzie, Michael ^c   Allin, Steven M ^d   Richardson, Alan ^a  

^a KEELE UNIVERSITY   (United Kingdom)

^b KEELE UNIVERSITY   (United Kingdom)

^c CHARNWOOD MOLECULAR LTD   (United Kingdom)

^d NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

Author keywords

Autotaxin; dendrimer; ovarian cancer; S32826

Indexed keywords

AUTOTAXIN; CARBOPLATIN; CASPASE 3; CASPASE 7; DENDRIMER; POLYAMIDOAMINE; POLYMER; PROTEIN INHIBITOR; S 32826; UNCLASSIFIED DRUG; [4 (TETRADECANOYLAMINO)BENZYL]PHOSPHONIC ACID;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CONJUGATE; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVATION; IC 50; OVARY CANCER; PRIORITY JOURNAL; STOICHIOMETRY;

EID: 84892583064     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml4003106     Document Type: Article

References (35)

1. Stracke, M. L.; Krutzsch, H. C.; Unsworth, E. J.; Arestad, A.; Cioce, V.; Schiffmann, E.; Liotta, L. A. Identification, purification, and partial sequence-analysis of autotaxin, a novel motility-stimulating protien J. Biol. Chem. 1992, 267 (4) 2524-2529
2. Clair, T.; Lee, H. Y.; Liotta, L. A.; Stracke, M. L. Autotaxin is an exoenzyme possessing 5′-nucleotide phosphodiesterase/ATP pyrophosphatase and ATPase activities J. Biol. Chem. 1997, 272 (2) 996-1001
3. Umezu-Goto, M.; Kishi, Y.; Taira, A.; Hama, K.; Dohmae, N.; Takio, K.; Yamori, T.; Mills, G. B.; Inoue, K.; Aoki, J.; Arai, H. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production J. Cell Biol. 2002, 158 (2) 227-33
4. Tokumura, A.; Majima, E.; Kariya, Y.; Tominaga, K.; Kogure, K.; Yasuda, K.; Fukuzawa, K. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase J. Biol. Chem. 2002, 277 (42) 39436-39442
5. Anliker, B.; Chun, J. Lysophospholipid G protein-coupled receptors J. Biol. Chem. 2004, 279 (20) 20555-20558
6. Hurst, J. H.; Mendpara, N.; Hooks, S. B. Regulator of G-protein signalling expression and function in ovarian cancer cell lines Cell. Mol. Biol. Lett. 2009, 14 (1) 153-174
7. Fang, X. J.; Schummer, M.; Mao, M. L.; Yu, S. X.; Tabassam, F. H.; Swaby, R.; Hasegawa, Y.; Tanyi, J. L.; LaPushin, R.; Eder, A.; Jaffe, R.; Erickson, J.; Mills, G. B. Lysophosphatidic acid is a bioactive mediator in ovarian cancer Biochim. Biophys. Acta, Mol. Cell Biol. Lipids 2002, 1582 (1-3) 257-264
8. Kanda, H.; Newton, R.; Klein, R.; Morita, Y.; Gunn, M. D.; Rosen, S. D. Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs Nature Immunol. 2008, 9 (4) 415-423
9. Pradère, J.-P.; Klein, J.; Grès, S.; Guigné, C.; Neau, E.; Valet, P.; Calise, D.; Chun, J.; Bascands, J.-L.; Saulnier-Blache, J.-S.; Schanstra, J. P. LPA1 Receptor Activation Promotes Renal Interstitial Fibrosis J. Am. Soc. Nephrol. 2007, 18 (12) 3110-3118
10. Tager, A. M.; LaCamera, P.; Shea, B. S.; Campanella, G. S.; Selman, M.; Zhenwen, Z.; Polosukhin, V.; Wain, J.; Karimi-Shah, B. A.; Kim, N. D.; Hart, W. K.; Pardo, A.; Blackwell, T. S.; Yan, X.; Chun, J.; Luster, A. D. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak Nat. Med. 2008, 14 (1) 45-54
11. Pamuklar, Z.; Federico, L.; Liu, S.; Umezu-Goto, M.; Dong, A.; Panchatcharam, M.; Fulerson, Z.; Berdyshev, E.; Natarajan, V.; Fang, X.; van Meeteren, L. A.; Moolenaar, W. H.; Mills, G. B.; Morris, A. J.; Smyth, S. S. Autotaxin/Lysopholipase D and Lysophosphatidic Acid Regulate Murine Hemostasis and Thrombosis J. Biol. Chem. 2009, 284 (11) 7385-7394
12. Xu, Y.; Gaudette, D. C.; Boynton, J. D.; Frankel, A.; Fang, X. J.; Sharma, A.; Hurteau, J.; Casey, G.; Goodbody, A.; Mellors, A.; Holub, B. J.; Mills, G. B. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 1995, 1 (10) 1223-1232
13. Tokumura, A.; Kume, T.; Fukuzawa, K.; Tahara, M.; Tasaka, K.; Aoki, J.; Arai, H.; Yasuda, K.; Kanzaki, H. Peritoneal fluids from patients with certain gynecologic tumor contain elevated levels of bioactive lysophospholipase D activity Life Sci. 2007, 80 (18) 1641-1649
14. Jazaeri, A. A.; Avvtrey, C. S.; Chandramouli, G. V. R.; Chuang, Y. E.; Khan, J.; Sotiriou, C.; Aprelikova, O.; Yee, C. J.; Zorn, K. K.; Birrer, M. J.; Barrett, J. C.; Boyd, J. Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers Clin. Cancer Res. 2005, 11 (17) 6300-6310
15. Vidot, S.; Witham, J.; Agarwal, R.; Greenhough, S.; Bamrah, H. S.; Tigyi, G. J.; Kaye, S. B.; Richardson, A. Autotaxin delays apoptosis induced by carboplatin in ovarian cancer cells Cell. Signal. 2010, 22 (6) 926-35
16. King-Underwood, J.; Allin, S. M.; Redman, C. W.; Richardson, A. Autotaxin-A Target for the Treatment of Drug-Resistant Ovarian Cancer? In Ovarian Cancer-Basic Science Perspective [Online on InTech ]; Farghaly, S. A., Ed.; 2012. http://www.intechopen.com/books/ovarian-cancer-basic-science- perspective/autotaxin-a-target-for-the-treatment-of-drug-resistant-ovarian- cancer-(accessed 06/11/13).
17. van Meeteren, L. A.; Ruurs, P.; Christodoulou, E.; Goding, J. W.; Takakusa, H.; Kikuchi, K.; Perrakis, A.; Nagano, T.; Moolenaar, W. H. Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate J. Biol. Chem. 2005, 280 (22) 21155-21161
18. Ferry, G.; Moulharat, N.; Pradere, J. P.; Desos, P.; Try, A.; Genton, A.; Giganti, A.; Beucher-Gaudin, M.; Lonchampt, M.; Bertrand, M.; Saulnier-Blache, J. S.; Tucker, G. C.; Cordi, A.; Boutin, J. A. S32826, a nanomolar inhibitor of autotaxin: discovery, synthesis and applications as a pharmacological tool J. Pharmacol. Exp. Ther. 2008, 327 (3) 809-19
19. Gierse, J.; Thorarensen, A.; Beltey, K.; Bradshaw-Pierce, E.; Cortes-Burgos, L.; Hall, T.; Johnston, A.; Murphy, M.; Nemirovskiy, O.; Ogawa, S.; Pegg, L.; Pelc, M.; Prinsen, M.; Schnute, M.; Wendling, J.; Wene, S.; Weinberg, R.; Wittwer, A.; Zweifel, B.; Masferrer, J. A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation J. Pharmacol. Exp. Ther. 2010, 334 (1) 310-7
20. Albers, H. M.; Dong, A.; van Meeteren, L. A.; Egan, D. A.; Sunkara, M.; van Tilburg, E. W.; Schuurman, K.; van Tellingen, O.; Morris, A. J.; Smyth, S. S.; Moolenaar, W. H.; Ovaa, H. Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation Proc. Natl. Acad. Sci. U. S. A. 2010, 107 (16) 7257-62
21. Esfand, R.; Tomalia, D. A. Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications Drug Discovery Today 2001, 6 (8) 427-436
22. Malik, N.; Wiwattanapatapee, R.; Klopsch, R.; Lorenz, K.; Frey, H.; Weenerc, J. W.; Meijerc, E. W.; Paulusd, W.; Duncan, R. Dendrimers: Relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo J. Controlled Release 2000, 63, 133-1448
23. Seymour, L. W.; Miyamoto, Y.; Maeda, H.; Brereton, M.; Strohalm, J.; Ulbrich, K.; Duncan, R. Influence of molecular-weight on passive tumor accumulation of a soluble macromolecular drug carrier Eur. J. Cancer 1995, 31A (5) 766-770
24. Maeda, H.; Seymour, L. W.; Miyamoto, Y. Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo Bioconjugate Chem. 1992, 3 (5) 351-362
25. Najlah, M.; Freeman, S.; Attwood, D.; D'Emanuele, A. Synthesis, characterization and stability of dendrimer prodrugs Int. J. Pharm. 2006, 308 (1-2) 175-182
26. Malik, N.; Evagorou, E. G.; Duncan, R. Dendrimer-platinate: a novel approach to cancer chemotherapy Anti-Cancer Drugs 1999, 10 (8) 767-776
27. Furui, T.; LaPushin, R.; Mao, M. Overexpression of Edg-2/vzg-1 Induces Apoptosis and Acid-independent Manner Anoikisin Ovarian Cancer Cells in a Lysophosphatidic Clin. Cancer Res. 1999, 5, 4308-4318
28. Roberts, J. C.; Bhalgat, M. K.; Zera, R. T. Preliminary biological evaluation of polyamidoamine (PAMAM) StarburstTM dendrimers J. Biomed. Mater. Res. 1996, 30 (1) 53-65
29. Ferguson, C. G.; Bigman, C. S.; Richardson, R. D.; van Meeteren, L. A.; Moolenaar, W. H.; Prestwich, G. D. Fluorogenic phospholipid substrate to detect lysophospholipase D/autotaxin activity Org. Lett. 2006, 8 (10) 2023-2026
30. Jiang, G.; Madan, D.; Prestwich, G. D. Aromatic phosphonates inhibit the lysophospholipase D activity of autotaxin Bioorg. Med. Chem. Lett. 2011, 21 (17) 5098-5101
31. Gaetano, C. G.; Samadi, N.; Tomsig, J. L.; Macdonald, T. L.; Lynch, K. R.; Brindley, D. N. Inhibition of Autotaxin Production or Activity Blocks Lysophosphatidylcholine-Induced Migration of Human Breast Cancer and Melanoma Cells Mol. Carcinog. 2009, 48 (9) 801-809
32. Zhang, H. L.; Xu, X. Y.; Gajewiak, J.; Tsukahara, R.; Fujiwara, Y.; Liu, J. X.; Fells, J. I.; Perygin, D.; Parrill, A. L.; Tigyi, G.; Prestwich, G. D. Dual Activity Lysophosphatidic Acid Receptor Pan-Antagonist/Autotaxin Inhibitor Reduces Breast Cancer Cell Migration In vitro and Causes Tumor Regression In vivo Cancer Res. 2009, 69 (13) 5441-5449
33. Saunders, L. P.; Ouellette, A.; Bandle, R.; Chang, W. C.; Zhou, H.; Misra, R. N.; De La Cruz, E. M.; Braddock, D. T. Identification of small-molecule inhibitors of autotaxin that inhibit melanoma cell migration and invasion Mol. Cancer Ther. 2008, 7 (10) 3352-62
34. Frankel, A.; Mills, G. B. Peptide and Lipid growth factors decrease cis-diamminedichloroplatinum-induced cell death in Human Ovarian Cancer Cells Clinical Cancer Res. 1996, 2, 1307-1313
35. Samadi, N.; Gaetano, C.; Goping, I. S.; Brindley, D. N. Autotaxin protects MCF-7 breast cancer and MDA-MB-435 melanoma cells against Taxol-induced apoptosis Oncogene 2009, 28 (7) 1028-1039